Cite
HARVARD Citation
Kang, W. et al. (2010). Serum hCG Level and Rising World Health Organization Score at Second-Line Chemotherapy (Pulse Dactinomycin): Poor Prognostic Factors for Methotrexate-Failed Low-Risk Gestational Trophoblastic Neoplasia. International journal of gynecological cancer. 20 (8), pp. 1424-1428. [Online].